@article{ref1,
title="A pilot randomized controlled trial of cognitive behavioral treatment for trauma-related nightmares in active duty military personnel",
journal="Journal of clinical sleep medicine",
year="2019",
author="Pruiksma, Kristi E. and Taylor, Daniel J. and Mintz, Jim and Nicholson, Karin L. and Rodgers, Matthew and Young-McCaughan, Stacey and Hall-Clark, Brittany N. and Fina, Brooke A. and Dondanville, Katherine A. and Cobos, Briana and Wardle-Pinkston, Sophie and Litz, Brett T. and Roache, John D. and Peterson, Alan L.",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="STUDY OBJECTIVES: The aim of this study was to obtain preliminary data on the efficacy, credibility, and acceptability of Exposure, relaxation, and rescripting therapy for military service members and veterans (ERRT-M) in active duty military personnel with trauma-related nightmares. <br><br>METHODS: Forty participants were randomized to either 5 sessions of ERRT-M or 5 weeks of minimal contact control (MCC) followed by ERRT-M. Assessments were completed at baseline, posttreatment/postcontrol, and 1-month follow-up. <br><br>RESULTS: Differences between ERRT-M and control were generally medium in size for nightmare frequency (Cohen <i>d = -</i>0.53), nights with nightmares (<i>d =</i> -0.38), nightmare severity (<i>d = -</i>0.60), fear of sleep (<i>d =</i> -0.44), and symptoms of insomnia (<i>d =</i> -0.52), and depression (<i>d =</i> -0.51). In the 38 participants who received ERRT-M, there were statistically significant, medium-sized decreases in nightmare frequency (<i>d</i> = -0.52), nights with nightmares (<i>d</i> = -0.50), nightmare severity (<i>d</i> = -0.55), fear of sleep (<i>d</i> = -0.48), and symptoms of insomnia (<i>d</i> = -0.59), posttraumatic stress disorder (PTSD) (<i>d</i> = -0.58) and depression (<i>d</i> = -0.59) from baseline to 1-month follow-up. Participants generally endorsed medium to high ratings of treatment credibility and expectancy. The treatment dropout rate (17.5%) was comparable to rates observed for similar treatments in civilians. <br><br>CONCLUSIONS: ERRT-M produced medium effect-size reductions in nightmares and several secondary outcomes including PTSD, depression, and insomnia. Participants considered ERRT-M to be credible. An adequately powered randomized clinical trial is needed to confirm findings and to compare ERRT-M to an active treatment control. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Title: A Pilot Randomized Controlled Trial of Treatment for Trauma-Related Nightmares In Active Duty Military Personnel; Identifier: NCT02506595; URL: https://clinicaltrials.gov/ct2/show/NCT02506595.<br><br>© 2019 American Academy of Sleep Medicine.<p /> <p>Language: en</p>",
language="en",
issn="1550-9389",
doi="",
url="http://dx.doi.org/"
}